Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.39 USD | -1.05% |
|
+2.47% | +70.89% |
| 07-02 | European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading | MT |
| 06-25 | European Equities Traded in US as ADRs Rise in Thursday Trading | MT |
| Market Cap | 367M 490M 429M 394M 697M 46.69B 707M 4.73B 1.84B 22.95B 1.84B 1.8B 79.09B | P/E 2026 * |
-17.4x | P/E 2027 * | -15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 221M 295M 258M 237M 419M 28.07B 425M 2.84B 1.11B 13.8B 1.11B 1.08B 47.55B | EV / Sales 2026 * |
88.5x | EV / Sales 2027 * | 34.2x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | -1.05% | ||
| 1 week | +2.47% | ||
| Current month | -5.37% | ||
| 1 month | +51.68% | ||
| 3 months | +74.92% | ||
| 6 months | +68.94% | ||
| Current year | +70.89% |
| 1 week | 9.96 |  | 11.06 |
| 1 month | 5.88 | | 11.06 |
| Current year | 4.19 | | 11.06 |
| 1 year | 4.19 | | 11.06 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 14/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 21/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/12/2019 |
Rhonda Hellums
BRD | Director/Board Member | 54 | 18/12/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-02 | Free | Director | 90,000 | 0.0635% | ||
| 01-02 | Free | Chief Technology Officer | 300,000 | 0.2117% | ||
| 01-02 | Free | Chief Financial Officer | 375,000 | 0.2646% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.05% | +2.47% | +88.22% | +74.62% | 491M | |
| +1.70% | +7.41% | +2.50% | +8.22% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +8.30% | +40.44% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +14.00% | +19.59% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +1.85% | +5.63% | +80.41% | +115.42% | 24.62B | |
| Weighted average by Cap. | +2.06% | +6.53% | +90.20% | +137.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 3.33M 2.91M 2.68M 4.73M 317M 4.8M 32.14M 12.49M 156M 12.51M 12.24M 537M | 3.44M 4.59M 4.02M 3.69M 6.53M 437M 6.63M 44.32M 17.23M 215M 17.25M 16.88M 741M |
| Net income | -50.34M -67.22M -58.77M -54.01M -95.48M -6.4B -96.93M -648M -252M -3.15B -252M -247M -10.84B | -84.67M -113M -98.84M -90.83M -161M -10.77B -163M -1.09B -424M -5.29B -424M -415M -18.23B |
| Net Debt | -146M -196M -171M -157M -278M -18.62B -282M -1.89B -733M -9.15B -734M -718M -31.54B | -249M -333M -291M -268M -473M -31.71B -480M -3.21B -1.25B -15.59B -1.25B -1.22B -53.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $10.39 | -1.05% | 696,727 |
| 01/07/26 | $10.50 | -4.37% | 718,986 |
| 30/06/26 | $10.98 | +1.76% | 556,751 |
| 29/06/26 | $10.79 | +6.41% | 1,151,446 |
| 26/06/26 | $10.14 | +1.40% | 1,080,895 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
